Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Related structures:
AlphaFold database: A4I308
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 200 | 204 | PF00656 | 0.572 |
CLV_NRD_NRD_1 | 49 | 51 | PF00675 | 0.544 |
CLV_PCSK_FUR_1 | 128 | 132 | PF00082 | 0.490 |
CLV_PCSK_KEX2_1 | 130 | 132 | PF00082 | 0.494 |
CLV_PCSK_KEX2_1 | 49 | 51 | PF00082 | 0.544 |
CLV_PCSK_PC1ET2_1 | 130 | 132 | PF00082 | 0.494 |
CLV_PCSK_SKI1_1 | 130 | 134 | PF00082 | 0.572 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.616 |
DEG_APCC_DBOX_1 | 163 | 171 | PF00400 | 0.488 |
DOC_PP2B_LxvP_1 | 15 | 18 | PF13499 | 0.569 |
DOC_USP7_MATH_1 | 178 | 182 | PF00917 | 0.531 |
DOC_USP7_MATH_1 | 61 | 65 | PF00917 | 0.639 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.719 |
DOC_WW_Pin1_4 | 206 | 211 | PF00397 | 0.639 |
DOC_WW_Pin1_4 | 59 | 64 | PF00397 | 0.642 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.536 |
DOC_WW_Pin1_4 | 8 | 13 | PF00397 | 0.765 |
LIG_14-3-3_CanoR_1 | 123 | 132 | PF00244 | 0.590 |
LIG_14-3-3_CanoR_1 | 49 | 53 | PF00244 | 0.553 |
LIG_APCC_ABBAyCdc20_2 | 49 | 55 | PF00400 | 0.559 |
LIG_CtBP_PxDLS_1 | 18 | 22 | PF00389 | 0.506 |
LIG_FHA_2 | 106 | 112 | PF00498 | 0.471 |
LIG_HCF-1_HBM_1 | 219 | 222 | PF13415 | 0.632 |
LIG_LIR_Apic_2 | 219 | 225 | PF02991 | 0.624 |
LIG_SH2_CRK | 222 | 226 | PF00017 | 0.624 |
LIG_SH2_CRK | 74 | 78 | PF00017 | 0.572 |
LIG_SH2_NCK_1 | 34 | 38 | PF00017 | 0.533 |
LIG_SH2_SRC | 34 | 37 | PF00017 | 0.534 |
LIG_SH2_STAP1 | 149 | 153 | PF00017 | 0.477 |
LIG_SH2_STAT3 | 115 | 118 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 115 | 118 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 230 | 233 | PF00017 | 0.607 |
LIG_SH2_STAT5 | 30 | 33 | PF00017 | 0.585 |
LIG_SH3_3 | 2 | 8 | PF00018 | 0.595 |
LIG_SH3_3 | 226 | 232 | PF00018 | 0.607 |
LIG_SH3_3 | 70 | 76 | PF00018 | 0.628 |
LIG_SH3_3 | 88 | 94 | PF00018 | 0.493 |
LIG_SUMO_SIM_par_1 | 75 | 80 | PF11976 | 0.568 |
MOD_CDK_SPxxK_3 | 59 | 66 | PF00069 | 0.644 |
MOD_CK1_1 | 20 | 26 | PF00069 | 0.559 |
MOD_GlcNHglycan | 145 | 148 | PF01048 | 0.507 |
MOD_GlcNHglycan | 222 | 225 | PF01048 | 0.603 |
MOD_GlcNHglycan | 239 | 242 | PF01048 | 0.482 |
MOD_GlcNHglycan | 85 | 89 | PF01048 | 0.761 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.665 |
MOD_GlcNHglycan | 97 | 100 | PF01048 | 0.544 |
MOD_GSK3_1 | 172 | 179 | PF00069 | 0.460 |
MOD_GSK3_1 | 233 | 240 | PF00069 | 0.583 |
MOD_GSK3_1 | 55 | 62 | PF00069 | 0.643 |
MOD_N-GLC_1 | 176 | 181 | PF02516 | 0.511 |
MOD_N-GLC_1 | 41 | 46 | PF02516 | 0.590 |
MOD_NEK2_1 | 41 | 46 | PF00069 | 0.590 |
MOD_PIKK_1 | 61 | 67 | PF00454 | 0.638 |
MOD_PKA_1 | 130 | 136 | PF00069 | 0.490 |
MOD_PKA_2 | 130 | 136 | PF00069 | 0.663 |
MOD_PKA_2 | 48 | 54 | PF00069 | 0.553 |
MOD_Plk_1 | 140 | 146 | PF00069 | 0.442 |
MOD_Plk_1 | 41 | 47 | PF00069 | 0.563 |
MOD_Plk_2-3 | 105 | 111 | PF00069 | 0.471 |
MOD_Plk_4 | 105 | 111 | PF00069 | 0.480 |
MOD_Plk_4 | 180 | 186 | PF00069 | 0.512 |
MOD_ProDKin_1 | 206 | 212 | PF00069 | 0.639 |
MOD_ProDKin_1 | 59 | 65 | PF00069 | 0.642 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.537 |
MOD_ProDKin_1 | 8 | 14 | PF00069 | 0.764 |
TRG_ENDOCYTIC_2 | 74 | 77 | PF00928 | 0.572 |
TRG_ER_diArg_1 | 164 | 167 | PF00400 | 0.487 |
TRG_Pf-PMV_PEXEL_1 | 158 | 163 | PF00026 | 0.473 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7X0X1 | Leishmania donovani | 99% | 100% |
E9ADI1 | Leishmania major | 88% | 100% |
E9AZA5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |